Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer

K. Hohenberger (Erlangen, Germany), D. Trufa (Erlangen, Germany), C. Gebbert (Erlangen, Germany), R. Rieker (Erlangen, Germany), H. Sirbu (Erlangen, Germany), S. Finotto (Erlangen, Germany)

Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session: Molecular alterations and immunology in lung cancer
Session type: E-poster session
Number: 1642
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Hohenberger (Erlangen, Germany), D. Trufa (Erlangen, Germany), C. Gebbert (Erlangen, Germany), R. Rieker (Erlangen, Germany), H. Sirbu (Erlangen, Germany), S. Finotto (Erlangen, Germany). Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer. 1642

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Induction of the transcriptional repressor B lymphocytes-induced maturation protein-1 (Blimp-1) in lung cancer
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020




Late Breaking Abstract - ERBB3 involved in growth factor pathway crosstalk during neonatal lung development in a 3D ex vivo model
Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Year: 2021



Downregulation of Thyroid transcription factor 1 in lung adenocarcinoma: the prognostic impact
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Transcription factor FOXF1 induces cancer-associated fibroblast-like phenotype to promote lung cancer progression
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



The role of FoxO transcription factors in normal and aberrant late lung development
Source: International Congress 2017 – Molecular pathways in lung development
Year: 2017

Expression of C/EBP transcription factors in mouse lung development
Source: Eur Respir J 2002; 20: Suppl. 38, 572s
Year: 2002

Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017

Late Breaking Abstract: Galectin-3 a key regulator in the development of lung fibrosis
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010

Late Breaking Abstract - Mapping fibroblast activity in IPF– the instructive lung ECM
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010

Late Breaking Abstract - Pigment epithelium-derived factor regulates cigarette-induced abnormal apoptosis of alveolar type II cells
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019

Transforming Growth factor beta-1 and Smad signaling has the potential to drive EMT-related changes in smokers and COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020




Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease.
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD.
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017

Asthma and diabetes: Possible markers of their co-existence. The possible role of transcription factors GATA-3 and T-bet and negative regulator of transcription SOCS1 in the worsening of asthma
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015

Targeted silencing of master transcription factor SPDEF to reduce mucus production in airway diseases by epigenetic editing
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015



Rac-specific nucleotide exchange factor Asef mediates lung endothelial barrier protection by hepatocyte growth factor
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014

Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016

Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms
Source: Eur Respir J 2012; 39: 705-711
Year: 2012